Design, Synthesis, and Biological Evaluation of Novel Transrepression-Selective Liver X Receptor (LXR) Ligands with 5,11-Dihydro-5-methyl-11-methylene-6H-dibenz[b,e]azepin-6-one Skeleton
- 8 August 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 55 (17) , 7360-7377
Abstract
To obtain novel transrepression-selective liver X receptor (LXR) ligands, we adopted a strategy of reducing the transactivational agonistic activity of the 5,11-dihydro-5-methyl-11-methylene-6H-dibenz[b,e]azepin-6-one derivative 10, which exhibits LXR-mediated transrepressional and transactivational activity. Structural modification of 10 based on the reported X-ray crystal structure of the LXR ligand-binding domain led to a series of compounds, of which almost all exhibited transrepressional activity at 1 or 10 μM but showed no transactivational activity even at 30 μM. Among the compounds obtained, 18 and 22 were confirmed to have LXR-dependent transrepressional activity by using peritoneal macrophages from wild-type and LXR-null mice. A newly developed fluorescence polarization assay indicated that they bind directly to LXRα. Next, further structural modification was performed with the guidance of docking simulations with LXRα, focusing on enhancing the binding of the ligands with LXRα through the introduction of substituents or heteroatom(s). Among the compounds synthesized, compound 48, bearing a hydroxyl group, showed potent, selective, and dose-dependent transrepressional activity.Keywords
This publication has 52 references indexed in Scilit:
- X-Ray Structures of the LXRα LBD in Its Homodimeric Form and Implications for Heterodimer SignalingJournal of Molecular Biology, 2010
- Structure-Based Design and Synthesis of Fluorescent PPAR.ALPHA./.DELTA. Co-agonist and Its Application as a Probe for Fluorescent Polarization Assay of PPAR.DELTA. LigandsChemical and Pharmaceutical Bulletin, 2008
- PXR and LXR in Hepatic Steatosis: A New Dog and an Old Dog with New TricksMolecular Pharmaceutics, 2007
- A Novel TLR4-Mediated Signaling Pathway Leading to IL-6 Responses in Human Bladder Epithelial CellsPLOS Pathogens, 2007
- Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytesJournal of Neuroimmunology, 2007
- Parallel SUMOylation-Dependent Pathways Mediate Gene- and Signal-Specific Transrepression by LXRs and PPARγMolecular Cell, 2007
- TLR signalingCell Death & Differentiation, 2006
- Combinatorial roles of nuclear receptors in inflammation and immunityNature Reviews Immunology, 2005
- A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γNature, 2005
- Liver X Receptor-dependent Repression of Matrix Metalloproteinase-9 Expression in MacrophagesJournal of Biological Chemistry, 2003